Salt solution may speed recovery for kids with pneumonia
NCT ID NCT06951347
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether giving children with pneumonia a daily oral rehydration solution (ORS) for three days could shorten their hospital stay. Researchers compared 140 children aged 1 month to 5 years who received ORS to those who did not. The goal was to see if this simple, low-cost supplement could help kids recover faster.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- oral rehydration solution (sodium and potassium)
- What this could lead to
- If it works, this could point toward a simple, low-cost way to help children with pneumonia recover faster in the hospital.
- What could go wrong
- This is a small, completed trial with 140 children. The intervention is a dietary supplement, not a direct treatment for pneumonia, so any benefit may be modest or not apply to all children.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
140 people
The number who actually took part.
- Started
-
May 2025
- Finished
-
Jun 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
1 month to 5 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Infants and children aged between 1 month and 5 years. * Patients diagnosed with pneumonia according to World Health Organization (WHO) criteria. Exclusion Criteria: * Children with other comorbidities. * Those whose parents will show disapproval for the participation of the study. * Children on medications that affect sodium and potassium levels.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Childhood pneumonia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mataria Teaching Hospital
Cairo, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.